Recent
price
P/E
ratio
div
yld
- -
ROIC.AI
•
in mil. unless spec.•
in mil. unless spec.•
in mil. unless spec.•
in mil. unless spec.•
in mil. unless spec.•
in mil. unless spec.Fortitude Reports Financial and Operating Results for the Nine Months Ended September 30, 2026
HeartSciences (NASDAQ:HSCS) Stock Breaks Above 200 Day Moving Average – What’s Next?
Is HeartSciences Inc. (HSCS) Stock Outpacing Its Medical Peers This Year?
HeartSciences Files Definitive Proxy Statement for Proposed Business Combination with Fortitude Mining
HeartSciences Receives FDA 510(k) Clearance for its MyoVista® wavECGTM Device
Fortitude Appoints Kimberly Pittman as Chief Legal Officer
HeartSciences Reports Fiscal First Quarter 2027 Financial Results and Provides Business Update
HeartSciences Inc. (HSCS) Reports Q1 Loss, Misses Revenue Estimates
Fortitude Invests $1.0 Million in HeartSciences at a 22% Premium with No Adjustment to the Merger Consideration
Fortitude Purchases 9,000 Bitmain Antminer Z15 Pro Units, Deepening Commitment to the Zcash Ecosystem
HeartSciences Files Preliminary Proxy Statement for Business Combination with Fortitude Mining Holdings; Provides Business Update and Reports Fiscal 2026 Financial Results
HeartSciences Files Its Fiscal 2026 Annual Report on Form 10-K
Fortitude and HeartSciences (Nasdaq: HSCS) Announce Business Combination, Aiming to Bring a Leading Vertically-Integrated Zcash Mining Platform to the Public Markets
European Patent Granted for ECG-Based Assessment of Diastolic Function, Expands HeartSciences' Patent Portfolio to More Than 45 Granted Patents
HeartSciences Launches MyoVista Insights™ Version 1.3 with AI-ECG Algorithm Marketplace and First FDA-Cleared Algorithm
HeartSciences Signs Commercial Agreement with North Shore Health, the First Hospital Deployment from the Cibolo Health Network
HeartSciences Signs First SaaS Revenues Agreement following full launch of MyoVista Insights™
Analyzing Rennova Health (OTCMKTS:RNVA) & HeartSciences (NASDAQ:HSCS)
HeartSciences Reminds Its Shareholders to Submit Their Vote at the Upcoming April 30, 2026, Annual Shareholders Meeting
Comparing 10x Genomics (NASDAQ:TXG) and HeartSciences (NASDAQ:HSCS)